- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02324764
Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography (CAPITAL-PRO)
Study Overview
Status
Intervention / Treatment
Detailed Description
Based on previously reported studies the rates of radial artery occlusion using a standard 6 Fr. sheath is around 5-10%, compared to the single feasibility study of the Glidesheath Slender by Aminian et al (see reference in the citations), the rate of radial artery occlusion was reported 0.88%.
This study will be a prospective randomized, single-blinded (patient-blinded) study, comparing the rate of radial artery occlusion and vascular access site complications between the Glidesheath Slender (Terumo, Tokyo, Japan) and the standard 6 Fr. radial sheath in patients undergoing transradial coronary catheterization.
- The study will enroll patients who will undergo elective or emergency coronary angiography and/or percutaneous coronary intervention (PCI) via transradial approach at the University of Ottawa Heart Institute.
- A baseline clinical vascular & ultrasound assessment will be performed prior to the procedure to document patency of the radial artery.
- Patients will be randomized in 1:1 fashion to either receive the Terumo Glidesheath Slender versus the currently used 6 Fr. sheath.
- The standard angiogram/ PCI will be performed as per usual practice.
- Following the angiogram, clinical vascular assessment as well as an ultrasound will be performed prior to discharge.
- At 30 days follow up the patient will come back for clinical and ultrasound assessment of radial artery patency and access site vascular complications.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y 4W7
- University of Ottawa Heart Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing coronary angiography and/or PCI via transradial approach
- Informed consent
- Documented normal Allen's test
Exclusion Criteria:
- Patient who had a previous angiogram using the same radial artery
- Abnormal Allen's test
- Previous failed radial access.
- Known bleeding disorder or hypercoagulable condition
- Cardiogenic shock
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Glidesheath Slender
The transradial procedure will be performed using the glidesheath slender (studied sheath)
|
testing the efficacy and safety of the new transradial sheath in comparison to the standard 6 french sheath.
Other Names:
|
Active Comparator: Standard sheath
The transradial procedure will be performed using the standard 6- French radial sheath (comparator sheath)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Radial artery occlusion
Time Frame: 30 days
|
Evaluated clinically and by ultrasound
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vascular access site complications
Time Frame: up to 30 days
|
Includes: Radial artery occlusion, bleeding or hematoma, pseudoaneurysm, artery dissection, compartment syndrome of the forearm
|
up to 30 days
|
Radial artery spasm
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 day
|
participants will be followed for the duration of hospital stay, an expected average of 1 day
|
|
Procedure success
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 day
|
Defined as ability to finish the angiogram/PCI via the intended access site, without the need to change access site.
|
participants will be followed for the duration of hospital stay, an expected average of 1 day
|
Sheath kinking
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 day
|
Major requiring sheath exchange or minor
|
participants will be followed for the duration of hospital stay, an expected average of 1 day
|
Painful sheath removal
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 day
|
Scored on a scale of 1-10 scoring system
|
participants will be followed for the duration of hospital stay, an expected average of 1 day
|
Collaborators and Investigators
Investigators
- Principal Investigator: Aun-Yeong Chong, MRCP, MD, University of Ottawa Heart Institute Research Corporation
Publications and helpful links
General Publications
- Kotowycz MA, Johnston KW, Ivanov J, Asif N, Almoghairi AM, Choudhury A, Nagy CD, Sibbald M, Chan W, Seidelin PH, Barolet AW, Overgaard CB, Dzavik V. Predictors of radial artery size in patients undergoing cardiac catheterization: insights from the Good Radial Artery Size Prediction (GRASP) study. Can J Cardiol. 2014 Feb;30(2):211-6. doi: 10.1016/j.cjca.2013.11.021. Epub 2013 Nov 23.
- Aminian A, Dolatabadi D, Lefebvre P, Zimmerman R, Brunner P, Michalakis G, Lalmand J. Initial experience with the Glidesheath Slender for transradial coronary angiography and intervention: a feasibility study with prospective radial ultrasound follow-up. Catheter Cardiovasc Interv. 2014 Sep 1;84(3):436-42. doi: 10.1002/ccd.25232. Epub 2013 Nov 6.
- Kotowycz MA, Dzavik V. Radial artery patency after transradial catheterization. Circ Cardiovasc Interv. 2012 Feb 1;5(1):127-33. doi: 10.1161/CIRCINTERVENTIONS.111.965871. No abstract available.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20140262
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Heart Disease
-
Peking University Third HospitalCompletedCoronary Microvascular Dysfunction | Obstructive Coronary Heart DiseaseChina
-
Shenyang Northern HospitalNot yet recruitingCoronary Heart Disease (CHD)China
-
Johns Hopkins UniversityCanon Medical Systems, USARecruiting
-
MedImmune LLCCompletedStable Coronary Heart DiseaseUnited States
-
Medical University of LodzBaxter Healthcare CorporationUnknownCHD - Coronary Heart DiseasePoland
-
University of ZurichCompletedStable Coronary Heart DiseaseSwitzerland
-
Hamad Medical CorporationMayo ClinicCompleted
-
Centro de estudios en Cardiologia IntervencionistaCompletedCoronary Heart Disease | Coronary RestenosisArgentina
-
Deutsches Herzzentrum MuenchenCompletedCoronary Heart DiseaseGermany
-
Henan Institute of Cardiovascular EpidemiologyNot yet recruitingStable Coronary Heart Disease
Clinical Trials on Glidesheath Slender
-
China National Center for Cardiovascular DiseasesUnknownCoronary Artery Disease | Radial Artery OcclusionChina
-
Wujin People's HospitalRecruitingCardiovascular Diseases | Coronary Artery DiseaseChina
-
University Hospital of PatrasCompletedRadial Artery Occlusion | Coronary Angiography | Arterial AccessGreece
-
NPO International TRI NetworkDuke Clinical Research Institute; European Cardiovascular Research CenterUnknownPercutaneous Coronary Intervention
-
Aarhus University Hospital SkejbyCompleted
-
David Kong, M.D.Medtronic Vascular; Terumo Medical Corporation; Volcano CorporationTerminatedMyocardial InfarctionUnited States